✦ LIBER ✦

208 DIAGNOSIS OF UNDERLYING DISEASE IN MEN WITH ERECTILE DYSFUNCTION RECEIVING PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE UNITED KINGDOM

✍ Scribed by M. Kirby; A. Marfatia; K.H. Zou; T. Symonds; G. Schnetzler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and detection rate of underly

✍ M. G. Kirby; G. Schnetzler; K.H. Zou; T. Symonds 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Erectile Dysfunction and Cardiovascular

✍ Nehra, Ajay 📂 Article 📅 2009 🏛 Mayo Clinic 🌐 English ⚖ 200 KB

Phosphodiesterase type 5 inhibitors for

✍ Vickers, M A; Satyanarayana, R 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Improvement in duration of erection foll

✍ M. T. Rosenberg; P. L. Adams; T. A. McBride; J. N. Roberts; S. W. McCallum 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Phosphodiesterase Type 5 Inhibitor Treat

✍ Lasaponara, Fedele; Sedigh, Omid; Pasquale, Giovanni; Bosio, Andrea; Rolle, Luig 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Factors associated with ejaculatory and

✍ Darius A. Paduch; Alexander Bolyakov; Anthony Beardsworth; Steven D. Watts 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB